Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Goodman signals on the open market ...
View:
Post by MrMugsy on Dec 05, 2020 4:22pm

Goodman signals on the open market ...

Goodman makes purchases as himself and as Long Zone Holdings.
If you're long on this one, that's what you want to see from the CEO.
In addition to regular monthly purchases.
Signalling value ... IMO.

Filed 2020-12-04 18:08
 
Tx date 2020-12-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,645
+9,800 vol
$5.27 each
496,236  
Filed 2020-12-04 09:46
 
Tx date 2020-12-03
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,250
+2,500 vol
$5.30 each
21,645,933  
Filed 2020-12-04 09:45
 
Tx date 2020-12-03
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$53,300
+10,000 vol
$5.33 each
21,643,433
Comment by Doccole on Dec 06, 2020 8:56am
It would be nice.   I expect significant news this week, early in the week. If we don't get news, we will slide some, and I will question the heck out of this plan!  
Comment by Danorrn on Dec 06, 2020 10:17am
If we don't get news this week it would signal to me that management wants bigger players to buy in but bigger players don't want to pay full price.
Comment by NotBornLastNite on Dec 06, 2020 4:12pm
Full Price....we are at a min 50% discount.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities